| Literature DB >> 22900193 |
Arinze S Okoli1, Mark J Raftery, George L Mendz.
Abstract
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths worldwide. Hepatitis B or C infections are the main causes of HCC with hepatitis C being the major risk factor for liver cancer in the developed countries. Recently, complications with bacteria of the genus Helicobacter have been associated with HCV-induced HCC. To further understand the mechanisms leading to the development of HCC in the presence of HCV and/or Helicobacter spp., investigation of the differential protein expression in Huh7 cells harbouring HCV-replicon, and replicon cured-Huh7 cells cocultured with H. bilis was done employing two-dimensional gel electrophoresis and mass spectrometry. In the transfected-Huh7 cells exposed to sublethal inoculum densities of H. bilis, 53 different proteins were identified comprising of 28 upregulated and 16 downregulated proteins including 9 potential protein isoforms; in the cured Huh7 cells, 45 different proteins were identified including 33 upregulated, 8 downregulated and, 9 potential protein isoforms. H. bilis affected the modulation of proteins involved in different pathways of Huh7-derived cells physiology including proteins involved in the progression from dysplasia to neoplasm. The result also indicated that the response of the Huh7-derived cells to the presence of H. bilis depended on whether or not HCV replicon was present.Entities:
Year: 2012 PMID: 22900193 PMCID: PMC3413985 DOI: 10.1155/2012/501671
Source DB: PubMed Journal: Int J Hepatol
Figure 1Growth of transfected- and cured Huh7 cells in cocultures with H. bilis at different inoculum densities. The initial number of Huh7 cells determined by the improved Neuber cytometer after staining with trypan blue was ca. 105.5 cells/ml. The number of viable Huh7 cells counted after 48 h in cocultures with H. bilis are shown in the figure. The values represent the mean count of Huh7 cells from three independent experiments.
Figure 22D-PAGE gels showing spots of soluble proteins of transfected and cured Huh7 cells in the pI 4–7 range. Gels (a) and (b) correspond to proteins of transfected Huh7 cells, gels (c) and (d) correspond to proteins of cured Huh7 cells. Cells were incubated in the presence of an initial H. bilis inoculum of approximately 103 cfu/mL. Protein spots in gels were visualised by silver staining. The spot intensities from triplicate gels of three independent experiments were determined using the Z3 computational software. Spots corresponding to proteins differentially expressed are indicated on the figure.
Proteins of transfected and cured Huh7 cells where expression was modulated in cocultures with H. bilis and identified by LC/MS-MS.
| n-Ffold (±SEM)b | Gene symbol | Functionc | Spot no. | Matching scored | ||||
|---|---|---|---|---|---|---|---|---|
| Proteina | T-Huh7e | C-Huh7f | T-Huh7 | C-Huh7 | T-Huh7 | C-Huh7 | ||
| Regulation of cell proliferation and structure | ||||||||
|
| ||||||||
| Vimentin∗ | 5 ± 0.01 | 3.6 ± 0.02 |
| 17 | 11 | 2228 | 1827 | |
| Vimentin∗ | 3 ± 0.03 | 2.3 ± 0.1 |
| 18 | 12 | 2166 | 1490 | |
| Tubulin beta | 0.4 ± 0.3 | 2.7 ± 0.3 |
| 14 | 21 | 112 | 962 | |
| Tubulin beta∗ | NI | 2.4 ± 0.5 |
| — | 45 | — | 341 | |
| Transmembrane protein 4 | 4.5 ± 0.04 | NI |
| 51 | — | 338 | — | |
| Stomatin-like 2 | NI | 2.4 ± 0.3 |
| Cytoskeleton and structural organization | — | 10 | — | 1272 |
| Beta actin | NI | 2.35 ± 0.04 |
| — | 24 | — | 560 | |
| Mutant beta-actin∗ | 2.7 ± 0.01 | NI |
| 20 | — | 166 | — | |
| Mutant beta-actin∗ | 2.1 ± 0.3 | NI |
| 38 | — | 161 | — | |
| Actin related protein 2/3 complex, subunit 5-like | 2.2 ± 0.1 | 0.4 ± 0.1 |
| 47 | 40 | 181 | 422 | |
| Stathmin 1 | 0.3 ± 0.1 | 3.2 ± 0.02 |
| 46 | 39 | 536 | 322 | |
|
| ||||||||
| Integrin beta 4 binding protein isoform a | 0.3 ± 0.01 | NI |
| Cell-matrix adhesion | 33 | — | 139 | — |
| Ran-binding protein 1 | 0.4 ± 0.1 | NI |
| 31 | — | 147 | — | |
|
| ||||||||
| Metabolism and Biosynthesis enzymes | ||||||||
|
| ||||||||
| Malate dehydrogenase | 0.4 ± 0.1 | NI |
| 10 | — | 451 | — | |
| Enolase∗ | 2.1 ± 0.3 | NI |
| 23 | — | 782 | — | |
| Enolase∗ | 4.2 ± 0.02 | NI |
| Energy metabolism | 53 | — | 800 | — |
| Triosephosphate isomerase 1 | 2.1 ± 0.3 | 2.6 ± 0.3 |
| 26 | 34 | 1115 | 1210 | |
| ATP synthase beta sub unit | 3.5 ± 0.2 | 2.4 ± 0.2 |
| 9 | 36 | 75 | 423 | |
| ATP synthase, H+ transporting mitochondrial F0 complex sub unit d isoform a | 2.1 ± 0.3 | NI |
| 35 | — | 139 | — | |
|
| ||||||||
| UV excision repair protein RAD23 homolog B | 2.1 ± 0.1 | NI |
| Nucleic acid metabolism (DNA repair) | 16 | — | 889 | — |
| Enoyl coenzyme A hydratase 1, peroxisomal | 4.8 ± 0.01 | NI |
| Fatty acid metabolism | 24 | — | 549 | — |
| Tryptophan 5-monooxygenase activation protein | NI | 2.7 ± 0.3 |
| Amino acid metabolism | — | 27 | — | 609 |
| Selenophosphate synthetase | NI | 4.3 ± 0.02 |
| — | 8 | — | 584 | |
| Pyrophosphatase 1 | NI | 3.7 ± 0.01 |
| Nucleotide metabolism | — | 22 | — | 201 |
|
| ||||||||
| Protein translation, Modification, and Degredation | ||||||||
|
| ||||||||
| Heterogeneous nuclear ribonucleoprotein | NI | 3.4 ± 0.03 |
| RNA processing | — | 6 | — | 870 |
|
| ||||||||
| Valosin-containing protein∗ | 0.4 ± 0.1 | NI |
| 1 | — | 3218 | — | |
| Valosin-containing protein∗ | 0.2 ± 0.1 | NI |
| 2 | — | 2178 | — | |
| Valosin-containing protein∗ | 0.4 ± 0.1 | NI |
| 3 | — | 1318 | — | |
| Prefoldin subunit 2 | 3.8 ± 0.02 | 2.9 ± 0.1 |
| 43 | 38 | 378 | 299 | |
| Cathepsin D preprotein | 2.7 ± 0.3 | 2.2 ± 0.3 |
| 27 | 9 | 370 | 615 | |
| Ubiquitin-conjugating enzyme E2N | 0.4 ± 0.3 | NI |
| 44 | — | 230 | — | |
| Ubiquilin 1∗ | 2.4 ± 0.01 | NI |
| 12 | — | 116 | — | |
| Ubiquilin 1∗ | 2.1 ± 0.3 | NI |
| Protein degradation | 13 | — | 602 | — |
| Ubiquitin carboxy-terminal hydrolase L1 | 0.3 ± 0.1 | NI |
| 30 | — | 230 | — | |
| Ubiquitin carboxyl-terminal esterase L3 | NI | 2.5 ± 0.06 |
| — | 29 | — | 320 | |
| S-phase kinase-associated protein 1A isoform b | 3.2 ± 0.05 | NI |
| 42 | — | 124 | — | |
| Proteasome alpha 3 subunit isoform 1 | 2.1 ± 0.3 | 4.1 ± 0.01 |
| 52 | 26 | 63 | 71 | |
| Proteasome 26S non-ATPase subunit 4 | 2.5 ± 0.1 | NI |
| 15 | — | 599 | — | |
| Prolyl 4-hydroxylase, alpha 1 subunit isoform 2 precursor | NI | 2.5 ± 0.03 |
| — | 5 | — | 888 | |
| Heme binding protein 2 | 2.8 ± 0.01 | NI |
| 32 | — | 107 | — | |
| Small glutamine-rich tetratricopeptide | NI | 0.1 ± 0.01 |
| — | 20 | — | 403 | |
|
| ||||||||
| Eukaryotic translation initiation factor 3 | 3.0 ± 0.02 | NI |
| 22 | — | 994 | — | |
| Eukaryotic translation initiation factor 5A∗ | 2.7 ± 0.1 | 2.3 ± 0.05 |
| 49 | 44 | 542 | 253 | |
| Eukaryotic translation initiation factor 5A∗ | 2.8 ± 0.1 | NI |
| Protein translation, modification, and | 50 | — | 147 | — |
| Eukaryotic translation elongation factor 1 delta isoform 2 | NI | 2.2 ± 0.4 |
| — | 18 | — | 627 | |
| Eukaryotic translation elongation factor 1 delta isoform 1 | NI | 0.4 ± 0.1 |
| — | 19 | — | 565 | |
| Human pre-mRNA splicing factor | NI | 2.1 ± 0.2 |
| — | 37 | — | 61 | |
|
| ||||||||
| Mitochondrial ribosomal protein L7L12∗ | NI | 2.1 ± 0.4 |
| Ribosomal structure, and biogenesis | — | 42 | — | 164 |
| Mitochondrial ribosomal protein L7L12∗ | NI | 2.4 ± 0.1 |
| — | 43 | — | 86 | |
|
| ||||||||
| Regulation of transcription | ||||||||
|
| ||||||||
| Basic transcription factor 3-like 4 | 0.4 ± 0.5 | NI |
| DNA binding | 36 | — | 106 | — |
| WD repeat domin 77 | NI | 2.5 ± 0.03 |
| Coordination of multiprotein complex | — | 14 | — | 166 |
|
| ||||||||
| Stress response | ||||||||
|
| ||||||||
| Mitochondria heat shock protein 75∗ | 2.3 ± 0.2 | 2.7 ± 0.1 |
| 4 | 1 | 1817 | 3016 | |
| Mitochondria heat shock protein 75∗ | 2.7 ± 0.5 | 3.1 ± 0.1 |
| 5 | 2 | 1817 | 2383 | |
| Heat shock 70 kDa protein 8 isoform 1∗ | 2.9 ± 0.1 | 2.3 ± 0.3 |
| Heat shock proteins and chaperones | 6 | 3 | 2463 | 2383 |
| Heat shock 70 kDa protein 8 isoform 1∗ | 2.6 ± 0.1 | 2.7 ± 0.1 |
| 7 | 4 | 1822 | 1792 | |
| Chaperonin | 2.3 ± 0.2 | NI |
| 21 | — | 1361 | — | |
| T-complex polypeptide 1 (chaperonin) | 0.15 ± 0.01 | NI |
| 8 | — | 336 | — | |
|
| ||||||||
| Superoxide dismutase copper chaperone | 0.35 ± 0.2 | NI |
| Oxidative stress response | 25 | — | 203 | — |
| Cu/Zn superoxide dismutase | 0.2 ± 0.03 | NI |
| 37 | — | 69 | — | |
|
| ||||||||
| Peroxiredoxin 2 isoform a | 2.4 ± 0.05 | 2.7 ± 0.2 |
| 34 | 35 | 564 | 78 | |
| Peroxiredoxin 3 isoform a precursor | NI | 2.5 ± 0.1 |
| Thio-specific antioxidant protein | — | 31 | — | 179 |
| Peroxiredoxin 4 | NI | 3.2 ± 0.05 |
| — | 30 | — | 782 | |
|
| ||||||||
| Thioredoxin-like 1 | NI | 0.37 ± 0.1 |
| Oxidoreductase activity | — | — | 17 | 758 |
| Endoplasmic reticulum thioredoxin superfamily member | 4.7 ± 0.01 | NI |
| 48 | — | 112 | — | |
|
| ||||||||
| CGI-150 protein | NI | 2.1 ± 0.1 |
| Response to toxin | — | 23 | — | 521 |
|
| ||||||||
| Signal transduction and transport | ||||||||
|
| ||||||||
| Progesterone receptor membrane component 1∗ | 0.3 ± 0.2 | NI |
| 40 | — | 322 | — | |
| Progesterone receptor membrane component 1∗ | 0.35 ± 0.4 | NI | Signal transduction | 41 | — | 294 | — | |
| Phospholipase C-alpha | 0.3 ± 0.03 | NI |
| 19 | — | 227 | — | |
| Glia maturation factor, beta | NI | 2.8 ± 0.01 |
| — | 41 | — | 233 | |
|
| ||||||||
| Sorcine isoform a | 3.1 ± 0.01 | NI |
| Transmembrane transporter protein | 39 | — | 320 | — |
| Calcium-binding mitochondrial carrier | NI | 0.2 ± 0.01 |
| — | 7 | — | 242 | |
|
| ||||||||
| Tumour-related | ||||||||
|
| ||||||||
| Tumor protein D52-like 2 isoform f | 3.7 ± 0.03 | NI |
| Tumorigenesis | 29 | — | 63 | — |
| Hepatoma-derived growth factor | NI | 2.9 ± 0.01 |
| Cellular proliferation and differentiation | — | 13 | — | 65 |
| Transformation upregulated nuclear protein | 4.2 ± 0.01 | NI |
| 54 | — | 116 | — | |
|
| ||||||||
| Rho GDP dissociation inhibitor alpha | NI | 2.3 ± 0.2 |
| — | 28 | — | 412 | |
| C-myc binding protein | 0.3 ± 0.03 | NI |
| 45 | — | 159 | — | |
| RAS related protein | NI | 3.1 ± 0.1 |
| — | 33 | — | 147 | |
| Immunity-related GTPase | 3.0 ± 0.3 | NI |
| Oncogene related | 11 | — | 125 | — |
| B23 nucleophosmin∗ | NI | 2.9 ± 0.1 |
| — | 15 | — | 1065 | |
| B23 nucleophosmin∗ | NI | 3.2 ± 0.1 |
| — | 16 | — | 1091 | |
| DJ-1 protein | NI | 0.2 ± 0.01 |
| — | 32 | — | 429 | |
|
| ||||||||
| Prohibitin | NI | 3.2 ± 0.1 |
| Negative regulator of apoptosis | — | 25 | — | 59 |
a Proteins were identified by LC-MS/MS and MASCOT searches of the NCBI nr database. bDifferential expression by at least 2-fold level of proteins of transfected or cured Huh7 cells exposed to sublethal concentration of H. bilis initial inoculum density of 103 cfu/mL; an n-fold value of >2 indicates upregulation, while a value of <0.5 indicates downregulation. cProteins were classified into functional categories based on the PANTHER, KEGG, Swiss-Prot and NCBI databases, and by reference to the published literature. dProteins with peptide matching score of >49 were considered significant for identification. ∗Protein isoforms. eTransfected Huh7 cells; fCured Huh7 cells.
Figure 3Relative expression of HCC-related genes in transfected- & cured Huh7 cells in response to H. bilis. Values are presented as log2 of the relative expression and represent the mean relative expression derived from biological triplicates. *P < 0.05.